← All organizations

Jacobus Pharmaceutical

For profitContributed to NME

Also known as: Jacobus | JACOBUS | JACOBUS PHARM CO INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Feb 1, 2022

Timeline

1970s

Jan 1, 1977
Jacobus Pharmaceutical— Founded
Jul 3, 1979
dapsone— NDA Organization

2010s

May 6, 2019
amifampridine phosphate— Marketing Organization

2020s

Feb 1, 2022
amifampridine phosphate— NDA Secondary Org

Drugs by trial phase (10 distinct, 15 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (3)

Recent trials (20)

NCT03062631CollaboratorN/AFeb 21, 2017
NCT02012933CollaboratorN/ADec 11, 2013
NCT01511978Study directorPhase 2Jan 1, 2012
NCT01511978Lead sponsorPhase 2Jan 1, 2012
NCT00994916CollaboratorN/AOct 8, 2009
NCT00495521Lead sponsorPhase 2Jun 1, 2007
NCT00495521Study chairPhase 2Jun 1, 2007
NCT00495521Study directorPhase 2Jun 1, 2007
NCT00417690Lead sponsorPhase 2Jan 1, 2007
NCT00417690Study directorPhase 2Jan 1, 2007
NCT00417690Study chairPhase 2Jan 1, 2007
NCT02090725CollaboratorN/AFeb 1, 2004
NCT00704925CollaboratorN/AJan 1, 2000
NCT00000640CollaboratorPhase 3Nov 2, 1999
NCT00001028CollaboratorPhase 3Nov 2, 1999

Details

Founded: Princeton, NJ, US Jan 1, 1977
First NDA: Jul 3, 1979
Last known activity: Feb 1, 2022